Unknown

Dataset Information

Long-term neurocognitive outcome is not worsened by of the use of venovenous ECMO in severe ARDS patients.


ABSTRACT:

Background

Venovenous extracorporeal membrane oxygenation (VV-ECMO) is associated with a significant morbidity. There is the need to investigate long-term cognitive outcome among ARDS survivors treated with VV-ECMO. We aimed to compare the prevalence of long-term cognitive dysfunction and neuropsychological impairment using a highly specific test in severe ARDS survivors treated or not treated with VV-ECMO.

Methods

Severe ARDS survivors treated between 2011 and 2017 in an ECMO Regional Referral Center were prospectively evaluated 2 years after their ICU discharge. Patients underwent an in-person interview and examination. The primary outcome was cognitive function, assessed by the Wechsler Adult Intelligence Scale 4th edition (WAIS-IV). Secondary outcomes included anxiety, d

SUBMITTER: Sylvestre A 

PROVIDER: S-EPMC6635548 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature